SunTrust Reiterates Buy Rating on Keurig Dr Pepper (KDP)

Go back to SunTrust Reiterates Buy Rating on Keurig Dr Pepper (KDP)

Pre-Open Movers 09/26: (MRNS) (BYND) (RAD) Higher; (PIR) (BTAI) (FDS) Lower (more...)

September 26, 2019 9:22 AM EDT

Today's Pre-Open Movers

Marinus Pharma (Nasdaq: MRNS) 37.2% HIGHER; announced that it has completed the top-line analysis of the open-label, dose-finding Phase 2 study evaluating intravenous (IV) ganaxolone in patients with refractory status epilepticus (RSE). Ganaxolone met the primary endpoint in the study with no patients (n=17) progressing to IV anesthetics within 24 hours of treatment initiation. Ganaxolone had an acceptable safety and tolerability profile for the RSE patient population in all dose groups. The... More

McDonald's USA (MCD) Enters Agreement with Keurig Dr Pepper (KDP) for McCafe Packaged Coffee

September 26, 2019 8:06 AM EDT

McDonald's USA (NYSE: MCD) and Keurig Dr Pepper (NYSE: KDP) today announced a long-term master licensing and distribution agreement for McCafé packaged coffee in the U.S. This new partnership, which brings together the national McCafé brand with Keurig Dr Pepper's leadership in specialty coffee and tea, represents the next chapter in the McCafé packaged coffee business that launched with Kraft Heinz in 2014.

Under the agreement, KDP will continue to be the exclusive manufacturer of McCafé K-Cup® pods in the U.S. KDP will also take on... More